£52.8m market cap
39.5p last close
Midatech Pharma is an ambitious speciality pharmaceutical company, founded in 2000. The patented gold nanoparticle technology platform is developing therapeutics for several diseases such as diabetes and various cancers.
Edison Investment Research is terminating coverage on Midatech Pharma (MTPH). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant.